Ultra-personal therapy: Gene tumor boards guide cancer care

Patient Alison Cairnes, left, looks at images with her doctor Shumei Kato, right, at the University of California San Diego in San Diego, Calif., on Aug. 15, 2017. Cairnes’ cancer was between her stomach and esophagus, and had spread to her liver, lungs and lymph nodes. Tissue testing found 10 abnormal genes, but on the liquid biopsy “only EGFR popped out” as a good target. Two drugs aim at that gene but aren’t approved for her type of cancer. A tumor board advised trying the combo. Within two weeks, she quit using pain medicines. After two months, her liver tumor had shrunk roughly by half. (AP Photo/Gregory Bull)

Click here and log in to view this story

Start Free AccountGet access to 7 premium stories every month for FREE!

Already a Subscriber?Current print subscriber? Activate your complimentary Digital account.

Subscribe NowChoose a package that suits your preferences.

Mike Pence's brother launches run for Indiana US House seat

The Latest: Sandusky to appeal ruling he won't get new trial

Share this story

0 Comments

Cancel reply

Your email address will not be published. Required fields are marked *

Name *

Email *

By participating in online discussions you acknowledge that you have agreed to the TERMS OF SERVICE. An insightful discussion of ideas and viewpoints is encouraged, but comments must be civil and in good taste, with no personal attacks. If your comments are inappropriate, you may be banned from posting. To report comments that you believe do not follow our guidelines, send us an email.

For security purposes, check this box before commenting